{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:07:15Z","timestamp":1778940435535,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"am","delay-in-days":324,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004008","name":"National Institute of Health","doi-asserted-by":"publisher","award":["U01DA038886"],"award-info":[{"award-number":["U01DA038886"]}],"id":[{"id":"10.13039\/501100004008","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-286532"],"award-info":[{"award-number":["MOP-286532"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["SKF-149507"],"award-info":[{"award-number":["SKF-149507"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Health Research BC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005247","name":"University of British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01DA038886"],"award-info":[{"award-number":["U01DA038886"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01-DA021525"],"award-info":[{"award-number":["U01-DA021525"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.josat.2023.209005","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T14:01:46Z","timestamp":1678716106000},"page":"209005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Interest in using buprenorphine-naloxone among a prospective cohort of street-involved young people in Vancouver, Canada"],"prefix":"10.1016","volume":"148","author":[{"given":"Andreas","family":"Pilarinos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Bingham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yandi","family":"Kwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Joe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cameron","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danya","family":"Fast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane A.","family":"Buxton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kora","family":"DeBeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2023.209005_bb0005","author":"Ahmad"},{"key":"10.1016\/j.josat.2023.209005_bb0010","article-title":"Microinduction of Buprenorphine\/Naloxone: A review of the literature","author":"Ahmed","year":"2020","journal-title":"The American Journal on Addictions"},{"issue":"4","key":"10.1016\/j.josat.2023.209005_bb0015","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jadohealth.2020.03.005","article-title":"Adolescent-serving addiction treatment facilities in the United States and the availability of medications for opioid use disorder","volume":"67","author":"Alinsky","year":"2020","journal-title":"Journal of Adolescent Health"},{"issue":"5","key":"10.1016\/j.josat.2023.209005_bb0020","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/dar.13113","article-title":"Use of a novel prescribing approach for the treatment of opioid use disorder: Buprenorphine\/naloxone micro-dosing: A case series","volume":"39","author":"Brar","year":"2020","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.josat.2023.209005_bb0025","series-title":"Did you know? Buprenorphine\/naloxone","year":"2017"},{"key":"10.1016\/j.josat.2023.209005_bb0030","author":"British Columbia Centre on Substance Use"},{"issue":"3","key":"10.1016\/j.josat.2023.209005_bb0045","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1360-0443.2002.00058.x","article-title":"Factors associated with non-fatal heroin overdose: Assessing the effect of frequency and route of heroin administration","volume":"97","author":"Brugal","year":"2002","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.josat.2023.209005_bb0050","doi-asserted-by":"crossref","first-page":"E247","DOI":"10.1503\/cmaj.170958","article-title":"Management of opioid use disorders: A national clinical practice guideline","volume":"190","author":"Bruneau","year":"2018","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.josat.2023.209005_bb0055","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/ADM.0000000000000359","article-title":"A case of opioid overdose and subsequent death following medically supervised withdrawal: The problematic role of rapid tapers for opioid use disorder","volume":"12","author":"Chang","year":"2018","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.josat.2023.209005_bb0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jadohealth.2020.01.016","article-title":"Medication treatment and health care use among adolescents with opioid use disorder in Ohio","volume":"67","author":"Chavez","year":"2020","journal-title":"Journal of Adolescent Health"},{"key":"10.1016\/j.josat.2023.209005_bb0065","doi-asserted-by":"crossref","DOI":"10.1186\/s13011-018-0180-3","article-title":"An age-based analysis of nonmedical prescription opioid use among people who use illegal drugs in Vancouver, Canada","volume":"13","author":"Cheng","year":"2018","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"key":"10.1016\/j.josat.2023.209005_bb0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jsat.2019.07.017","article-title":"Factors impeding switching from methadone to buprenorphine in heroin users receiving methadone maintenance therapy-a naturalistic cohort study","volume":"105","author":"Chung","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.josat.2023.209005_bb0075","doi-asserted-by":"crossref","first-page":"09","DOI":"10.1542\/peds.2016-1893","article-title":"Medication-assisted treatment of adolescents with opioid use disorders [practice guideline review]","volume":"138","author":"Committee On Substance Use Prevention","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.josat.2023.209005_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109624","article-title":"Predictors of crystal methamphetamine use initiation or re-initiation among people receiving opioid agonist therapy: A prospective cohort study","volume":"240","author":"Cui","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.josat.2023.209005_bb0085","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/dar.13017","article-title":"High-dose buprenorphine for treatment of high potency opioid use disorder","volume":"39","author":"Danilewitz","year":"2020","journal-title":"Drug and Alcohol Review"},{"issue":"1","key":"10.1016\/j.josat.2023.209005_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13011-015-0046-x","article-title":"Inability to access addiction treatment predicts injection initiation among street-involved youth in a Canadian setting","volume":"11","author":"DeBeck","year":"2016","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"key":"10.1016\/j.josat.2023.209005_bb0095","article-title":"The deepening opioid crisis in North America: Historical context and current solutions","volume":"1\u201310","author":"Donroe","year":"2018","journal-title":"Current Addiction Reports"},{"issue":"2","key":"10.1016\/j.josat.2023.209005_bb0100","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/maq.12638","article-title":"Going nowhere: Ambivalence about drug treatment during an overdose public health emergency in Vancouver","volume":"35","author":"Fast","year":"2021","journal-title":"Medical Anthropology Quarterly"},{"issue":"6","key":"10.1016\/j.josat.2023.209005_bb0105","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jadohealth.2016.12.023","article-title":"Medication-assisted treatment for adolescents in specialty treatment for opioid use disorder","volume":"60","author":"Feder","year":"2017","journal-title":"Journal of Adolescent Health"},{"issue":"4","key":"10.1016\/j.josat.2023.209005_bb0110","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jadohealth.2012.07.011","article-title":"Homelessness independently predicts injection drug use initiation among street-involved youth in a Canadian setting","volume":"52","author":"Feng","year":"2013","journal-title":"Journal of Adolescent Health"},{"key":"10.1016\/j.josat.2023.209005_bb0115","series-title":"The Canadian Encyclopedia: Historica Canada","article-title":"Inuit","author":"Freeman","year":"2020"},{"issue":"1","key":"10.1016\/j.josat.2023.209005_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13722-017-0092-y","article-title":"More beds are not the answer: Transforming detoxification units into medication induction centers to address the opioid epidemic","volume":"12","author":"Friedmann","year":"2017","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.josat.2023.209005_bb0125","series-title":"The Canadian Encyclopedia: Historica Canada","article-title":"First nations","author":"Gadacz","year":"2022"},{"key":"10.1016\/j.josat.2023.209005_bb0130","series-title":"The Canadian Encyclopedia: Historica Canada","article-title":"M\u00e9tis","author":"Gaudry","year":"2019"},{"key":"10.1016\/j.josat.2023.209005_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ssmph.2020.100609","article-title":"Opioid agonist therapy trajectories among street entrenched youth in the context of a public health crisis","volume":"11","author":"Giang","year":"2020","journal-title":"SSM - Population Health"},{"key":"10.1016\/j.josat.2023.209005_bb0140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.socscimed.2017.01.053","article-title":"\u201cThey treated me like crap and I know it was because I was native\u201d: The healthcare experiences of Aboriginal peoples living in Vancouver's inner city","volume":"178","author":"Goodman","year":"2017","journal-title":"Social Science & Medicine"},{"key":"10.1016\/j.josat.2023.209005_bb0145","series-title":"Recovery services & treatment support: Substance use treatment options","year":"2020"},{"key":"10.1016\/j.josat.2023.209005_bb0150","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.evalprogplan.2017.10.005","article-title":"Response to culturally competent drug treatment among homeless persons with different living arrangements","volume":"66","author":"Guerrero","year":"2018","journal-title":"Evaluation and Program Planning"},{"issue":"2 Supplement 1","key":"10.1016\/j.josat.2023.209005_bb0155","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jadohealth.2017.11.033","article-title":"Use of evidence-based medication treatment among medicaid-enrolled youth with opioid use disorder, 2014\u20132015 [Conference Abstract]","volume":"62","author":"Hadland","year":"2018","journal-title":"Journal of Adolescent Health"},{"issue":"1\u20132","key":"10.1016\/j.josat.2023.209005_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2008.10.012","article-title":"Access to drug and alcohol treatment among a cohort of street-involved youth","volume":"101","author":"Hadland","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.josat.2023.209005_bb0165","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ypmed.2012.08.015","article-title":"Childhood sexual abuse and risk for initiating injection drug use: A prospective cohort study","volume":"55","author":"Hadland","year":"2012","journal-title":"Preventive Medicine"},{"key":"10.1016\/j.josat.2023.209005_bb0170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/SAR.S109919","article-title":"Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: The Bernese method","volume":"7","author":"H\u00e4mmig","year":"2016","journal-title":"Substance Abuse and Rehabilitation"},{"issue":"7","key":"10.1016\/j.josat.2023.209005_bb0175","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1007\/s10461-013-0563-4","article-title":"A peer-educator network HIV prevention intervention among injection drug users: Results of a randomized controlled trial in St. Petersburg, Russia","volume":"17","author":"Hoffman","year":"2013","journal-title":"AIDS and Behavior"},{"key":"10.1016\/j.josat.2023.209005_bb0180","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jsat.2018.08.011","article-title":"Buprenorphine treatment formulations: Preferences among persons in opioid withdrawal management","volume":"94","author":"Kenney","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209005_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108404","article-title":"The cascade of care for opioid use disorder among youth in British Columbia, 2018","volume":"130","author":"Krebs","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"6","key":"10.1016\/j.josat.2023.209005_bb0195","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/jama.2018.6566","article-title":"Increasing fatality rates from preventable deaths in teenagers and young adults","volume":"320","author":"Lee","year":"2018","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.josat.2023.209005_bb0200","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s10461-012-0373-0","article-title":"Peer-education intervention to reduce injection risk behaviors benefits high-risk young injection drug users: A latent transition analysis of the CIDUS 3\/DUIT study","volume":"17","author":"Mackesy-Amiti","year":"2013","journal-title":"AIDS and Behavior"},{"issue":"11","key":"10.1016\/j.josat.2023.209005_bb0205","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/oxfordjournals.aje.a116813","article-title":"Simulation study of confounder-selection strategies","volume":"138","author":"Maldonado","year":"1993","journal-title":"American Journal of Epidemiology"},{"issue":"6","key":"10.1016\/j.josat.2023.209005_bb0210","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1521-0391.2010.00086.x","article-title":"Buprenorphine-based regimens and methadone for the medical management of opioid dependence: Selecting the appropriate drug for treatment","volume":"19","author":"Maremmani","year":"2010","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.josat.2023.209005_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109471","article-title":"Factors associated with perceived decline in the quality of drugs during the COVID-19 pandemic: Evidence from community-recruited cohorts of people who use drugs in VancouverCanada","volume":"236","author":"McAdam","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.josat.2023.209005_bb0220","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0376-8716(03)00057-7","article-title":"Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: Why the 4: 1 ratio for treatment?","volume":"70","author":"Mendelson","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209005_bb0225","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.drugalcdep.2018.12.018","article-title":"Opioid agonist treatment and the process of injection drug use initiation","volume":"197","author":"Mittal","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209005_bb0230","article-title":"Systematic review on effectiveness of micro-induction approaches to buprenorphine initiation","volume":"114","author":"Moe","year":"2020","journal-title":"Addictive Behaviors"},{"issue":"1","key":"10.1016\/j.josat.2023.209005_bb0235","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/add.14769","article-title":"Coercion into addiction treatment and subsequent substance use patterns among people who use illicit drugs in Vancouver, Canada [Article]","volume":"115","author":"Pilarinos","year":"2020","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.josat.2023.209005_bb0240","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/jamapediatrics.2021.4606","article-title":"Access to medications for opioid use disorder and associated factors among adolescents and young adults: A systematic review","volume":"176","author":"Pilarinos","year":"2022","journal-title":"JAMA Pediatrics"},{"issue":"6","key":"10.1016\/j.josat.2023.209005_bb0245","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1001\/jamapediatrics.2022.0474","article-title":"Centering young People\u2019s perspectives, needs, and preferences in research regarding barriers to medications for opioid use disorder\u2014Reply","volume":"176","author":"Pilarinos","year":"2022","journal-title":"JAMA Pediatrics"},{"key":"10.1016\/j.josat.2023.209005_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109441","article-title":"Initiation of opioid agonist treatment and subsequent substance use and other patterns among adolescents and young adults in VancouverCanada","volume":"235","author":"Pilarinos","year":"2022","journal-title":"Drug and alcohol dependence"},{"issue":"0","key":"10.1016\/j.josat.2023.209005_bb0255","article-title":"Methadone maintenance treatment discontinuation among young people use who opioids in Vancouver, Canada","volume":"0","author":"Pilarinos","year":"2022","journal-title":"The Canadian Journal of Psychiatry"},{"key":"10.1016\/j.josat.2023.209005_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103773","article-title":"Navigating opioid agonist therapy among young people who use illicit opioids in VancouverCanada","volume":"107","author":"Pilarinos","year":"2022","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.josat.2023.209005_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13011-016-0053-6","article-title":"Factors associated with inability to access addiction treatment among people who inject drugs in Vancouver, Canada","volume":"11","author":"Prangnell","year":"2016","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"2\u20133","key":"10.1016\/j.josat.2023.209005_bb0270","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.drugalcdep.2007.04.006","article-title":"Sublingual buprenorphine\/naloxone precipitated withdrawal in subjects maintained on 100 mg of daily methadone","volume":"90","author":"Rosado","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209005_bb0275","series-title":"Modern epidemiology","author":"Rothman","year":"2008"},{"issue":"12","key":"10.1016\/j.josat.2023.209005_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225548","article-title":"Assessing service and treatment needs and barriers of youth who use illicit and non-medical prescription drugs in northern OntarioCanada","volume":"14","author":"Russell","year":"2019","journal-title":"Plos One"},{"key":"10.1016\/j.josat.2023.209005_bb0285","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.drugpo.2019.09.003","article-title":"\u201cEverything is not right anymore\u201d: Buprenorphine experiences in an era of illicit fentanyl","volume":"74","author":"Silverstein","year":"2019","journal-title":"International Journal of Drug Policy"},{"issue":"7396","key":"10.1016\/j.josat.2023.209005_bb0290","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1136\/bmj.326.7396.959","article-title":"Loss of tolerance and overdose mortality after inpatient opiate detoxification: Follow up study","volume":"326","author":"Strang","year":"2003","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.josat.2023.209005_bb0295","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.jaac.2011.07.010","article-title":"Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine\/naloxone treatment trial in opioid-dependent youth","volume":"50","author":"Subramaniam","year":"2011","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"key":"10.1016\/j.josat.2023.209005_bb0300","series-title":"In plain sight: Addressing indigenous-specific racism and discrimination in BC health care","author":"Turpel-Lafond","year":"2021"},{"key":"10.1016\/j.josat.2023.209005_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107672","article-title":"Willingness to take buprenorphine\/naloxone among people who use opioids in VancouverCanada","volume":"205","author":"Weicker","year":"2019","journal-title":"Drug and alcohol dependence"},{"issue":"1","key":"10.1016\/j.josat.2023.209005_bb0310","first-page":"1","article-title":"Evaluating methamphetamine use and risks of injection initiation among street youth: The ARYS study","volume":"3","author":"Wood","year":"2006","journal-title":"Harm Reduction Journal"},{"issue":"1","key":"10.1016\/j.josat.2023.209005_bb0315","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1874473711104010028","article-title":"Buprenorphine and buprenorphine\/naloxone diversion, misuse, and illicit use: An international review","volume":"4","author":"Yokell","year":"2011","journal-title":"Current Drug Abuse Reviews"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923000553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923000553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:11:09Z","timestamp":1778937069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923000553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":60,"alternative-id":["S2949875923000553"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209005","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interest in using buprenorphine-naloxone among a prospective cohort of street-involved young people in Vancouver, Canada","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"209005"}}